[HTML][HTML] Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT)

C Mussini, M Falcone, S Nozza, C Sagnelli… - Clinical Microbiology …, 2021 - Elsevier
Scope Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has
become pandemic, reaching almost one million death worldwide. At present standard …

[HTML][HTML] Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-Infective Therapy …

M Bassetti, DR Giacobbe, S Aliberti, E Barisione… - Clinical Microbiology …, 2020 - Elsevier
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the
causative agent of coronavirus disease 2019 (COVID-19), which has rapidly become …

Treatment options for COVID-19: a review

MJ Ali, M Hanif, MA Haider, MU Ahmed… - Frontiers in …, 2020 - frontiersin.org
Background: The recent COVID-19 pandemic sweeping the globe has caused great concern
worldwide. Due to the limited evidence available on the dynamics of the virus and effective …

Updated approaches against SARS-CoV-2

H Li, Y Zhou, M Zhang, H Wang… - Antimicrobial agents and …, 2020 - Am Soc Microbiol
Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lies behind the
ongoing outbreak of coronavirus disease 2019 (COVID-19). There is a growing …

Treatment of SARS-CoV-2: How far have we reached?

W Ahsan, S Javed, M Al Bratty, HA Alhazmi… - Drug discoveries & …, 2020 - jstage.jst.go.jp
The virus severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is currently
affecting more than 200 countries and territories worldwide. It has been declared as …

Coronavirus disease 2019 treatment: a review of early and emerging options

EK McCreary, JM Pogue - Open forum infectious diseases, 2020 - academic.oup.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus
disease 2019 (COVID-19), has spread across the globe resulting in a pandemic. At the time …

[HTML][HTML] Therapeutic options for COVID-19: a review

R Pujari, MV Thommana, BR Mercedes, A Serwat - Cureus, 2020 - ncbi.nlm.nih.gov
An acute respiratory disease caused by a novel coronavirus [severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), previously known as 2019-nCoV], the coronavirus …

National institute for the infectious diseases “L. Spallanzani”, IRCCS. Recommendations for COVID-19 clinical management

E Nicastri, N Petrosillo, TA Bartoli, L Lepore… - Infectious disease …, 2020 - mdpi.com
On January 9 2020, the World Health Organization (WHO) declared the identification, by
Chinese Health authorities, of a novel coronavirus, further classified as SARS-CoV-2 …

Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline

Z Ye, B Rochwerg, Y Wang, NK Adhikari, S Murthy… - Cmaj, 2020 - Can Med Assoc
2019 (COVID-19) is either indirect (from studies of influenza, severe acute respiratory
syndrome and Middle East respiratory syndrome) or from several observational studies and …

Potential therapeutic options for COVID-19: current status, challenges, and future perspectives

C Sarkar, M Mondal, M Torequl Islam… - Frontiers in …, 2020 - frontiersin.org
The COVID-19 pandemic represents an unprecedented challenge for the researchers to
offer safe, tolerable, and effective treatment strategies for its causative agent known as …